Work

Abstract 1765: RPT1G, a first-in-class hyperbolic NAMPT inhibitor that avoids on-target toxicity

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-1765

Authors: Gregory Thomas Crimmins, Min Wu, Timothy Jarvela, Yushma Bhurruth-Alcor, James Digel, Francis Roushar, Dexter Davis, Caroline M. Robb, Michael Schelle, Banumathi Cole, Frank McCormick, Dennise A. De Jesús-Díaz

Institution: UCSF Helen Diller Family Comprehensive Cancer Center

Language: English

Topic: Sirtuins and Resveratrol in Medicine

Subfield: Geriatrics and Gerontology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409627143

Cites:

Cited by:

Related to: 10